HONG KONG — A small molecule has been shown to be capable of breaking down amyloid beta deposits in a study of the brains of mice exhibiting the symptoms of Alzheimer's disease (AD), an important finding that may lead to the development of new treatments for the different stages of AD, according to the results of a study by Korean researchers.